Literature DB >> 8517028

Regulation of the late events in flavivirus protein processing and maturation.

V F Yamshchikov1, R W Compans.   

Abstract

In order to determine the requirements for secretion of flavivirus structural proteins, we analyzed the expression of several West Nile flavivirus gene cassettes of different lengths in vaccinia virus expression systems. Expression of the longest cassette coding for the 5'-nontranslated region, proteins C through NS2B, and the protease domain of NS3, resulted in secretion of prM-E complexes and cleavage of prM. The presence and proper processing of the NS2A-NS2B-NS3 region appeared to be necessary for prM-E secretion. These proteins were released from cells mostly as membranous complexes which may represent empty viral envelopes. Cleavage of the membrane-associated intracellular form of protein C (C(i)) to produce the virion form (Ce) appeared to be critical for release of viral proteins. The presence and proper cleavage of the NS2A-NS2B-NS3 region were also found to be necessary for efficient C-prM cleavage by signalases. The NS2B-NS3 complex was implicated in cleavage of the intracellular form of protein C. Formation of a low level of virus-like particles was detected by electron microscopy. A model for virion formation, suggesting a critical role of the NS2B and NS3 proteins, is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8517028     DOI: 10.1006/viro.1993.1006

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  32 in total

1.  Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum.

Authors:  M P Courageot; M P Frenkiel; C D Dos Santos; V Deubel; P Desprès
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing.

Authors:  S M Amberg; C M Rice
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

3.  Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence.

Authors:  Regina M Kofler; Franz X Heinz; Christian W Mandl
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles.

Authors:  Beate M Kümmerer; Charles M Rice
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

5.  Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranes.

Authors:  Mario Lobigs; Eva Lee
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

6.  Mutagenesis of the signal sequence of yellow fever virus prM protein: enhancement of signalase cleavage In vitro is lethal for virus production.

Authors:  E Lee; C E Stocks; S M Amberg; C M Rice; M Lobigs
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Translation of the flavivirus kunjin NS3 gene in cis but not its RNA sequence or secondary structure is essential for efficient RNA packaging.

Authors:  Gorben P Pijlman; Natasha Kondratieva; Alexander A Khromykh
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

8.  Construction and characterization of a single-cycle chimeric flavivirus vaccine candidate that protects mice against lethal challenge with dengue virus type 2.

Authors:  Ryosuke Suzuki; Evandro R Winkelmann; Peter W Mason
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

9.  NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies.

Authors:  S M Amberg; A Nestorowicz; D W McCourt; C M Rice
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  Isolation of capsid protein dimers from the tick-borne encephalitis flavivirus and in vitro assembly of capsid-like particles.

Authors:  Stefan Kiermayr; Regina M Kofler; Christian W Mandl; Paul Messner; Franz X Heinz
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.